Neuroprotective and Anti-inflammatory Effects of Pioglitazone on Traumatic Brain Injury
Traumatic brain injury (TBI) is still a major cause of concern for public health, and out of all the trauma-related injuries, it makes the highest contribution to death and disability worldwide. Patients of TBI continue to suffer from brain injury through an intricate flow of primary and secondary i...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2022/9860855 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554976837107712 |
|---|---|
| author | Mohammad Yassin Zamanian Niloofar Taheri Maria Jade Catalan Opulencia Dmitry Olegovich Bokov Sharif Y. Abdullaev Mohammadreza Gholamrezapour Mahsa Heidari Gholamreza Bazmandegan |
| author_facet | Mohammad Yassin Zamanian Niloofar Taheri Maria Jade Catalan Opulencia Dmitry Olegovich Bokov Sharif Y. Abdullaev Mohammadreza Gholamrezapour Mahsa Heidari Gholamreza Bazmandegan |
| author_sort | Mohammad Yassin Zamanian |
| collection | DOAJ |
| description | Traumatic brain injury (TBI) is still a major cause of concern for public health, and out of all the trauma-related injuries, it makes the highest contribution to death and disability worldwide. Patients of TBI continue to suffer from brain injury through an intricate flow of primary and secondary injury events. However, when treatment is provided in a timely manner, there is a significant window of opportunity to avoid a few of the serious effects. Pioglitazone (PG), which has a neuroprotective impact and can decrease inflammation after TBI, activates peroxisome proliferator-activated receptor-gamma (PPARγ). The objective of the study is to examine the existing literature to assess the neuroprotective and anti-inflammatory impact of PG in TBI. It also discusses the part played by microglia and cytokines in TBI. According to the findings of this study, PG has the ability to enhance neurobehavior, decrease brain edema and neuronal injury following TBI. To achieve the protective impact of PG the following was required: (1) stimulating PPARγ; (2) decreasing oxidative stress; (3) decreasing nuclear factor kappa B (NF-κB), interleukin 6 (IL-6), interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2), and C-C motif chemokine ligand 20 (CCL20) expression; (4) limiting the increase in the number of activated microglia; and (5) reducing mitochondrial dysfunction. The findings indicate that when PIG is used clinically, it may serve as a neuroprotective anti-inflammatory approach in TBI. |
| format | Article |
| id | doaj-art-dc2e7502ec5843bb9774a846fe6ecdc9 |
| institution | Kabale University |
| issn | 1466-1861 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-dc2e7502ec5843bb9774a846fe6ecdc92025-02-03T05:49:57ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/9860855Neuroprotective and Anti-inflammatory Effects of Pioglitazone on Traumatic Brain InjuryMohammad Yassin Zamanian0Niloofar Taheri1Maria Jade Catalan Opulencia2Dmitry Olegovich Bokov3Sharif Y. Abdullaev4Mohammadreza Gholamrezapour5Mahsa Heidari6Gholamreza Bazmandegan7Neurophysiology Research CenterStudent Research CommitteeCollege of Business Administration Ajman UniversityInstitute of PharmacyDepartment of Maxillo-facial diseases and TraumatologyClinical Research Development UnitDepartment of BiochemistryDepartment of Family MedicineTraumatic brain injury (TBI) is still a major cause of concern for public health, and out of all the trauma-related injuries, it makes the highest contribution to death and disability worldwide. Patients of TBI continue to suffer from brain injury through an intricate flow of primary and secondary injury events. However, when treatment is provided in a timely manner, there is a significant window of opportunity to avoid a few of the serious effects. Pioglitazone (PG), which has a neuroprotective impact and can decrease inflammation after TBI, activates peroxisome proliferator-activated receptor-gamma (PPARγ). The objective of the study is to examine the existing literature to assess the neuroprotective and anti-inflammatory impact of PG in TBI. It also discusses the part played by microglia and cytokines in TBI. According to the findings of this study, PG has the ability to enhance neurobehavior, decrease brain edema and neuronal injury following TBI. To achieve the protective impact of PG the following was required: (1) stimulating PPARγ; (2) decreasing oxidative stress; (3) decreasing nuclear factor kappa B (NF-κB), interleukin 6 (IL-6), interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2), and C-C motif chemokine ligand 20 (CCL20) expression; (4) limiting the increase in the number of activated microglia; and (5) reducing mitochondrial dysfunction. The findings indicate that when PIG is used clinically, it may serve as a neuroprotective anti-inflammatory approach in TBI.http://dx.doi.org/10.1155/2022/9860855 |
| spellingShingle | Mohammad Yassin Zamanian Niloofar Taheri Maria Jade Catalan Opulencia Dmitry Olegovich Bokov Sharif Y. Abdullaev Mohammadreza Gholamrezapour Mahsa Heidari Gholamreza Bazmandegan Neuroprotective and Anti-inflammatory Effects of Pioglitazone on Traumatic Brain Injury Mediators of Inflammation |
| title | Neuroprotective and Anti-inflammatory Effects of Pioglitazone on Traumatic Brain Injury |
| title_full | Neuroprotective and Anti-inflammatory Effects of Pioglitazone on Traumatic Brain Injury |
| title_fullStr | Neuroprotective and Anti-inflammatory Effects of Pioglitazone on Traumatic Brain Injury |
| title_full_unstemmed | Neuroprotective and Anti-inflammatory Effects of Pioglitazone on Traumatic Brain Injury |
| title_short | Neuroprotective and Anti-inflammatory Effects of Pioglitazone on Traumatic Brain Injury |
| title_sort | neuroprotective and anti inflammatory effects of pioglitazone on traumatic brain injury |
| url | http://dx.doi.org/10.1155/2022/9860855 |
| work_keys_str_mv | AT mohammadyassinzamanian neuroprotectiveandantiinflammatoryeffectsofpioglitazoneontraumaticbraininjury AT niloofartaheri neuroprotectiveandantiinflammatoryeffectsofpioglitazoneontraumaticbraininjury AT mariajadecatalanopulencia neuroprotectiveandantiinflammatoryeffectsofpioglitazoneontraumaticbraininjury AT dmitryolegovichbokov neuroprotectiveandantiinflammatoryeffectsofpioglitazoneontraumaticbraininjury AT sharifyabdullaev neuroprotectiveandantiinflammatoryeffectsofpioglitazoneontraumaticbraininjury AT mohammadrezagholamrezapour neuroprotectiveandantiinflammatoryeffectsofpioglitazoneontraumaticbraininjury AT mahsaheidari neuroprotectiveandantiinflammatoryeffectsofpioglitazoneontraumaticbraininjury AT gholamrezabazmandegan neuroprotectiveandantiinflammatoryeffectsofpioglitazoneontraumaticbraininjury |